Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.33)
# 1,010
Out of 5,141 analysts
27
Total ratings
55%
Success rate
4.65%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: In-Line | $105 → $110 | $103.10 | +6.69% | 4 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Outperform | $370 → $340 | $241.89 | +40.56% | 2 | Feb 19, 2026 | |
| TECH Bio-Techne | Maintains: In-Line | $62 → $68 | $57.52 | +18.22% | 4 | Feb 5, 2026 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $390 → $320 | $241.12 | +32.71% | 4 | Feb 3, 2026 | |
| RMBS Rambus | Maintains: Outperform | $126 → $119 | $102.64 | +15.94% | 3 | Feb 3, 2026 | |
| DXCM DexCom | Initiates: In-Line | $68 | $73.08 | -6.95% | 1 | Nov 25, 2025 | |
| NTRA Natera | Maintains: Outperform | $190 → $250 | $212.12 | +17.86% | 2 | Nov 7, 2025 | |
| RGEN Repligen | Maintains: Outperform | $155 → $175 | $135.68 | +28.98% | 4 | Oct 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $59.53 | +109.98% | 2 | Oct 7, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $134.25 | +15.46% | 1 | Sep 16, 2025 |
Guardant Health
Feb 20, 2026
Maintains: In-Line
Price Target: $105 → $110
Current: $103.10
Upside: +6.69%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $370 → $340
Current: $241.89
Upside: +40.56%
Bio-Techne
Feb 5, 2026
Maintains: In-Line
Price Target: $62 → $68
Current: $57.52
Upside: +18.22%
West Pharmaceutical Services
Feb 3, 2026
Maintains: Outperform
Price Target: $390 → $320
Current: $241.12
Upside: +32.71%
Rambus
Feb 3, 2026
Maintains: Outperform
Price Target: $126 → $119
Current: $102.64
Upside: +15.94%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $73.08
Upside: -6.95%
Natera
Nov 7, 2025
Maintains: Outperform
Price Target: $190 → $250
Current: $212.12
Upside: +17.86%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155 → $175
Current: $135.68
Upside: +28.98%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $59.53
Upside: +109.98%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $134.25
Upside: +15.46%